within Pharmacolibrary.Drugs.ATC.C;

model C01CA26
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.000395,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.215,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 900
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01CA26</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ephedrine is a sympathomimetic amine used as a medication and stimulant. Historically, it has been used for the treatment of asthma, nasal congestion, and low blood pressure, especially during anesthesia. Today, its use is limited due to side effects and the availability of safer alternatives. It is not widely approved for general medical use in many countries, but still used in specific circumstances, such as anesthesia-induced hypotension.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Kanfer, I, et al., &amp; Vuma, V (1993). Pharmacokinetics of oral decongestants. <i>Pharmacotherapy</i> 13(6 Pt 2) 116S–146S. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7507589/\">https://pubmed.ncbi.nlm.nih.gov/7507589</a></p></li><li><p>Wellington, K, &amp; Jarvis, B (2001). Cetirizine/pseudoephedrine. <i>Drugs</i> 61(15) 2231–2242. DOI:<a href=\"https://doi.org/10.2165/00003495-200161150-00009\">10.2165/00003495-200161150-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11772135/\">https://pubmed.ncbi.nlm.nih.gov/11772135</a></p></li><li><p>Pickup, ME, et al., &amp; Paterson, JW (1976). The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. <i>British journal of clinical pharmacology</i> 3(1) 123–134. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1976.tb00579.x\">10.1111/j.1365-2125.1976.tb00579.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/973934/\">https://pubmed.ncbi.nlm.nih.gov/973934</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01CA26;
